Leveraging Novel Targets, Advanced Engineering & Clinical Strategies to Expand Patient Populations for In-Market Success of TCR-Based Cell & Biologic Therapies
The past few years for the TCR community have been dynamic. Approvals have signalled a viable path to commercialization, while a wave of company closures highlight the deep-rooted challenges in the current development processes. The message is clear: success is not guaranteed at approval. Addressing manufacturing costs, durability and long-term commercial viability is now mission critical for developers of TCR-based cell and biologic therapies.
Spanning the full therapeutic landscape, including TCR-T, TCR mimetics, TCR-TCEs and TCR bispecifics, the annual TCR-Based Therapies Summit cuts through the noise to focus exclusively on the challenges most acutely impacting the TCR field today. Attendees connected directly with senior leaders driving progress at the forefront of the field, including C-suite leaders from Immunocore, Immatics, T-knife Therapeutics, Anocca, Zelluna Immunotherapy, Enara Bio, Marengo Therapeutics, and 3T Biosciences.
With the foundations now in place, this annual meeting is designed to empower the community to shape a more durable, scalable, and commercially robust future for TCR-based therapies.
We heard great updates from the field of TCR-based therapies. I was able to participate in excellent discussions and interactions thanks to the chairmans
Chief Scientific Officer, CDR-Life, 2024 Speaker
It was a highly focused meeting with a representative from almost all of the top biotech companies in the field
Associate Director, Immatics, 2024 Attendee
This is the only conference focusing on TCR-based therapeutics. The intimate size of the meeting permitted for frequent discussions with other participants
Head, Translational Medicine, Engimmune Therapeutics, 2025 Attendee
Attending Companies Included
Delve into the Complete 2026 Event Program
Find Inside...
- Interactive Workshops on Next-Generation TCR Targets & Novel Engineering Strategies
- Unrivalled Networking Opportunities with Industry-Leading TCR Developers
- Brand-New Data Presentations Led by Top Biopharma Professionals
- Insight into the Only Meeting Dedicated to TCR-Based Therapy Advancement
Speaker Faculty Included
Official 2026 Partners
Explore Related Events
Discover the 2026 Agenda
See the agenda delivering the latest breakthroughs and real-world insights on TCR-T, TCR mimetics, TCR-TCEs, and TCR bispecifics.
Partner With the Future
Position your brand at the center of the TCR ecosystem by partnering with leading developers shaping the future of TCR-based therapies.
Collaborate With TCR Experts
Connect with senior leaders across biopharma and academia during high-value networking sessions and the scientific poster session.